Serum cytokines as a biomarker for immune checkpoint inhibitor toxicity in patients with pleural mesothelioma

BackgroundPleural mesothelioma (PM) is a rare cancer with a dismal prognosis. Dual immune checkpoint inhibitors have improved overall survival, but the rate of immune-related adverse events (irAEs) is high. Serum cytokines reflect systemic immune reactions and may serve as biomarkers for irAEs.Patie...

詳細記述

書誌詳細

出版年:	Frontiers in Immunology
主要な著者:	Saima Jamil Farooqi, Zhi Zhao, Åsa Kristina Öjlert, Solfrid Thunold, Hedvig Vidarsdotter Juul, Maria Moksnes Bjaanæs, Henrik Horndalsveen, Hanne Marte Gjertsen Nymoen, Åslaug Helland, Vilde Drageset Haakensen
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2024-12-01
主題:	pleural mesothelioma immunotherapy biomarkers cytokines checkpoint inhibition blockade
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1480183/full